文献速递类风湿关节炎

类风湿关节炎发病前诱导免疫耐受:以自身免疫反应为靶点

The autoimmune response as a potential target for tolerance induction before the development of rheumatoid arthritis.
PubMed 文献 · Lancet Rheumatol · 2021-02-24

本文为Lancet Rheumatol的系列综述,聚焦类风湿关节炎(RA)发病前的自身免疫反应及耐受诱导策略。文章梳理RA特异性自身免疫从健康状态向疾病过渡的演变过程,并讨论以预防或治愈RA为目标的耐受研究设计思路。

要点

  • RA目前无法治愈或预防,需终身用药且残留疾病活动可致功能丧失
  • 理解并永久沉默RA相关自身免疫反应(即诱导耐受)是实现治愈与预防的关键
  • 预防研究需先识别可预测未来发病的临床、免疫学和生物学标志物以锁定高危人群

核心结论

  • RA仍无法治愈或预防,诱导耐受有望实现无药缓解与发病前预防

研究设计与样本

  • 系列综述(Series paper),回顾RA自身免疫反应及耐受研究设计思路

主要发现

  • RA特异性自身免疫在健康向疾病过渡期间逐步发生和演变
  • 残留疾病活动导致肌肉骨骼系统进行性功能丧失及关节外疾病负担

临床怎么用

  • 需识别预测未来发病的临床、免疫学和生物学标志物以筛选高危人群开展预防研究

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Rheumatoid arthritis is a chronic inflammatory disease that affects the synovial joints. Although treatment options and efficacy have increased substantially in the past two decades, the disease cannot be cured or prevented. Therefore, rheumatoid arthritis still has a considerable effect on the quality of life of patients, not only because life-long medication is often required, but also because residual disease activity leads to progressive loss of function in the musculoskeletal system and extra-articular morbidity. Key future goals in the management of rheumatoid arthritis are the ability to induce long-lasting drug-free remission in patients with the disease (ie, to achieve a cure), and to prevent disease before it emerges. To reach these goals, it is pivotal to understand the autoimmune response underlying rheumatoid arthritis pathogenesis and to develop ways to permanently silence it (ie, to induce tolerance). For preventive studies, the identification of markers (clinical, immunological, and biological) predictive of future disease is crucial, as prevention of disease will not be feasible without the ability to identify relevant at-risk target populations. In this Series paper, we review the autoimmune response underlying rheumatoid arthritis, how rheumatoid arthritis-specific autoimmunity develops and evolves during the transition from health to disease, and how tolerance studies could be designed to achieve prevention or cure of the disease.

来源:Lancet Rheumatol,查看原文。版权归原作者所有。

引用

  1. Toes RE, Raza K. The autoimmune response as a potential target for tolerance induction before the development of rheumatoid arthritis. Lancet Rheumatol. 2021. PMID: 38279384. doi:10.1016/S2665-9913(20)30445-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。